The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

One group across the UK is being urged to get three vaccines as winter flu cases surge, putting increased pressure on NHS ...

It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

Researchers evaluated the real-world effectiveness of nirsevimab in preventing ICU admission and acute respiratory failure associated with RSV among infants.

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Learn about the FDA's review of the safety of RSV prevention drugs Clesrovimab and Nirsevimab for infants and toddlers. Find ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

RSV vaccines were 58% effective at preventing RSV-associated hospitalizations among adults age 60 or older across two seasons. Vaccine effectiveness against all-cause cardiorespiratory ...

Learn what happens to cells inside the nose during an RSV infection, and why infants are so vulnerable to the virus.